Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia. [electronic resource]
Producer: 20020523Description: 2245-7 p. digitalISSN:- 0006-4971
- Adult
- Aged
- Alemtuzumab
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bone Marrow -- pathology
- Drug Resistance
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- diagnosis
- Male
- Middle Aged
- Remission Induction
- Therapeutic Equivalency
- Treatment Outcome
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.